PGHH Declares ₹60 Dividend for FY26; TDS Rules Updated
PGHH declared a final dividend of ₹60 per equity share for FY26, subject to AGM approval. The company updated shareholders on TDS regulations for dividend income as per the Income Tax Act, 2025. Shareholders must submit updated details and forms by August 14, 2026, to ensure correct TDS application.
The dividend declaration is a positive event for shareholders. However, the detailed information on TDS and compliance requirements impacts all shareholders, requiring them to take specific actions.
The announcement is primarily informational regarding dividend declaration and TDS compliance, without any significant positive or negative financial performance indicators.
Procter & Gamble Hygiene and Health Care Limited (PGHH) announced that its Board of Directors, in a meeting held on May 28, 2026, declared a final dividend of ₹60 per equity share of face value ₹10 each for the Financial Year 2025-26. This dividend is subject to the approval of the shareholders at the upcoming Annual General Meeting (AGM).
The Company has also provided updated information regarding the deduction of tax at source (TDS) on dividend income, in compliance with the Income Tax Act, 2025, as amended by the Finance Act, 2026. Dividends declared and paid after April 1, 2020, are taxable in the hands of shareholders, requiring PGHH to deduct TDS at applicable rates.
Shareholders are requested to update their records, including tax residential status, PAN, and contact details, with their respective depositories or the company's registrar, M/s. MUFG Intime India Private Limited. Specific guidelines and documentation requirements are outlined for both resident and non-resident shareholders to determine the appropriate TDS rate. For resident shareholders, TDS will be 10% if PAN is available and nil if Form 121 is furnished under eligible conditions. For non-resident shareholders, the TDS rate is 20% plus applicable surcharge and cess, or the DTAA rate, whichever is lower, subject to submission of required documentation.
The company has also specified that declarations under Rule 203 for transferring TDS credit to the beneficial owner must be made by August 14, 2026. Shareholders are urged to submit all necessary forms and documents for the Financial Year 2026-27 by this date to ensure correct TDS application. Incomplete or late submissions may result in higher TDS rates, and any claims for refunds will need to be processed through the shareholder's income tax return.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.